Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant

M. Driskel (Manchester, United Kingdom), A. Horsley (Manchester, United Kingdom), M. Al-Aloul (Manchester, United Kingdom)

Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Session: Treatments and biomarkers for lung allograft function and outcome
Session type: Oral Presentation
Number: 4728

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Driskel (Manchester, United Kingdom), A. Horsley (Manchester, United Kingdom), M. Al-Aloul (Manchester, United Kingdom). Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant. 4728

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung clearance index (LCI) as a sensitive marker of post-transplant bronchiolitis obliterans syndrome (BOS)
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018

The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx)
Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Year: 2007


Interferon-γ, IL-17 and MMP-9 in early and late bronchiolitis obliterans (BO) following experimental lung transplantation in rats
Source: Eur Respir J 2007; 30: Suppl. 51, 517s
Year: 2007

Can we predict development of bronchiolitis obliterans syndrome (BOS) according to parameters of oxidative stress in lung transplant recipients?
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007


Proteomic analysis of broncho alveolar lavage fluid (BAL-f) in lung transplant recipients (LTR) with bronchiolitis obliterans syndrome (BOS)
Source: Eur Respir J 2006; 28: Suppl. 50, 120s
Year: 2006

Forced oscillometry for early detection of bronchiolitis obliterans (BO) following hematogenous stem cell transplant (HSCT)
Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Year: 2018



Pulmonary distribution of oxygen partial pressure in lung transplant recipients: assessment by oxygen-sensitive 3He-MRI to indicate bronchiolitis obliterans (BO)
Source: Eur Respir J 2005; 26: Suppl. 49, 176s
Year: 2005

Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Validation of a bronchiolitis obliterans rat lung transplant model: the role of MMP-9
Source: Eur Respir J 2006; 28: Suppl. 50, 778s
Year: 2006

Plasma CRP levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008



The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007


The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome
Source: Eur Respir Rev 2008; 17: 90-92
Year: 2008



High resolution CT in children with non transplant obliterative bronchiolitis (OB) and problematic asthma. Correlation with lung function
Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology
Year: 2010


Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011


Do nitrites (NO2) and nitrates (NO3) have a role in the development of bronchiolitis obliterans syndrome (BOS) in lung transplant recipients?
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Lung clearance index in detection of post-transplant bronchiolitis obliterans syndrome
Source: ERJ Open Res, 5 (4) 00164-2019; 10.1183/23120541.00164-2019
Year: 2019



Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011


Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003



Acinar ventilation heterogeneity (Sacin) assessed by nitrogen multiple breath washout is an accurate and sensitive marker of bronchiolitis obliterans (BO)
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

Early diagnosis of chronic rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005